BrightHeart, a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, today announced the closing of an €11 million Series A financing round. The round was co-led by Odyssée ...
6d
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
Johnson & Johnson today announced that the company has submitted the OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback